Comparison of the efficacy of SVF injection in the treatment of alopecia

Phase 2

• Conditions: Hair loss.; Androgenic alopecia, unspecified; L64.9

• Registration Number: IRCT20200127046282N8
• Lead Sponsor: Skin and Stem Cell Research Center, Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 4 April 2022

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

men and women with inherited hormonal hair loss
Age 18 years and older and less than 50 years
Hamilton scores 2 to 5 in men and Ludwig scores 1 to 3 in women
Complete patient consent to participate in the project

Exclusion Criteria

Platelet disorders
Thrombocytopenia
Patients receiving anticoagulants
Patients with malignancy
Receiving chemotherapy during the last 5 years
Patients with sepsis
Being a smoker
Pregnancy
Active wound or infection at the treatment site
Do not receive any topical or systemic medication in the last 3 months
Women with hyperprolactinemia
Women with hormonal disorders or polycystic ovaries

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The amount of hair loss. Timepoint: Before treatment and two month after the last session. Method of measurement: Trichoscan.

Secondary Outcome Measures

Name	Time	Method
Side effects. Timepoint: One week after session. Method of measurement: Questionnaire and visit.;Satisfaction. Timepoint: Two months after the last session. Method of measurement: Questionnaire and visit.;Tolerability. Timepoint: Each session after transplantation. Method of measurement: Questionnaire and visit.